HTLF Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$336K Sell
5,933
-472
-7% -$26.4K 0.04% 158
2024
Q3
$331K Buy
6,405
+16
+0.3% +$751 0.04% 165
2024
Q2
$265K Sell
6,389
-366
-5% -$16.4K 0.03% 190
2024
Q1
$366K Sell
6,755
-411
-6% -$20.9K 0.04% 166
2023
Q4
$368K Buy
+7,166
New +$376K 0.04% 158

Other funds holding BMY

HTLF Bank's BMY Position: Q4 2024 in Review

HTLF Bank reduced its Bristol-Myers Squibb (BMY) stake by 7.4% in Q4 2024, selling an estimated $26.4K and leaving 5,933 shares worth $336K. The position accounts for 0.04% of the portfolio, ranked #158.

HTLF Bank first reported a position in BMY in Q4 2023 and has held it in 5 quarters since. The position peaked at $368K in Q4 2023. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • HTLF Bank held 5,933 shares of Bristol-Myers Squibb worth $336K as of Q4 2024.
  • HTLF Bank sold 472 Bristol-Myers Squibb shares in Q4 2024, an estimated $26.4K.
  • Bristol-Myers Squibb made up 0.04% of HTLF Bank's portfolio in Q4 2024, its #158 holding.
  • HTLF Bank first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 5 quarters since.
  • HTLF Bank's Bristol-Myers Squibb position peaked at $368K in Q4 2023.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on HTLF Bank's 13F filing for Q4 2024, filed 28 Jan 2025.